TAK-226

· Takeda

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-226, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAK-226 for Transfusion-Dependent Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes [Phase 2]

See pricing